Cytori Therapeutics Inc., of San Diego, said an investigator-sponsored trial has been cleared to start in France to study the company's cell therapy as a potential treatment for limited and diffuse cutaneous systemic sclerosis.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST